Category archives: Biomedicine

TREM2 acts as a receptor for IL-34 to suppress acute myeloid leukemia in mice

TREM2 acts as a receptor for IL-34 to suppress acute myeloid leukemia in mice

Biomedicine

By Invited Researcher

Acute myeloid leukemia (AML) is a stem cell disease caused by the massive mobilization and differentiation arrest in primordial granulocytes. AML is characterized by a low survival rate and high recurrence . Although differentiation-induction therapy represents an innovative treatment strategy for AML , many problems still exist, including irreversible resistance, toxic effects, and limitations of […]

Remodeling of the immune microenvironment in B-ALL leukemia

Remodeling of the immune microenvironment in B-ALL leukemia

Biomedicine

By Invited Researcher

Acute B-cell progenitor acute lymphoblastic leukemia (B-ALL) is a clonal hematopoietic neoplasm characterized by the proliferation and accumulation of B-lymphoid progenitor cells throughout the bone marrow. Although important studies have characterized the underlying biological pathways that underpin therapy failure , resistance and subsequent relapse remain a leading cause of cancer-related deaths . One approach to […]

Targeting mitochondrial structure sensitizes acute myeloid leukemia to Venetoclax treatment

Targeting mitochondrial structure sensitizes acute myeloid leukemia to Venetoclax treatment

Biomedicine

By Invited Researcher

Acute Myeloid Leukemia (AML) is a hematopoietic neoplasm characterized by the proliferation and accumulation of aberrant immature myeloid progenitor cells. AML is associated with poor clinical outcome and high mortality, with an overall five-year survival rate of less than 15-30%. For AML patients, standard therapies often fail to achieve the complete remission, disease relapse is […]

Antibody-drug conjugates for the treatment of acute myeloid leukemia

Antibody-drug conjugates for the treatment of acute myeloid leukemia

Biomedicine

By Invited Researcher

Acute myeloid leukemia (AML) is the most common acute leukemia in adults and a common pediatric cancer. Most often, AML develops from cells that would turn into white blood cells. AML is divided into different subtypes based on the cell type and maturation stage. Currently, monocytic AML, including acute myelomonocytic leukemia (M4) and acute monocytic […]